Novartis Promises Growth Despite 'Historic' Patent Cliffs - I Broadly Agree
Source: SeekingAlpha
2026-03-23 16:41:07 ET
Investment Overview - Novartis Latest M&A Deal Speaks to Pipeline Pressure
A few days ago (March 20th), Swiss Pharmaceuticals giant Novartis ( NVS ) announced it would pay $2bn up front (the deal may rise to $3bn if milestones are met) to acquire Pikavation Therapeutics, a wholly owned subsidiary of Synnovation, a privately owned Biotech headquartered in Delaware....
Read the full article on Seeking Alpha
For further details see:
Novartis Promises Growth Despite 'Historic' Patent Cliffs - I Broadly Agree
Novartis AG
NASDAQ: NVS
NVS Trading
0.86% G/L:
$151.80 Last:
846,635 Volume:
$151.58 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
February 22, 2026 03:07:00 pm
Novartis: This Big Pharma Giant Could Be a Sleep?at?Night Core Holding for Decades
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
